Status:
ACTIVE_NOT_RECRUITING
Using Lidocaine or Dexmedetomidine to Help Control Blood Pressure Spikes From a Tourniquet During Knee Surgery
Lead Sponsor:
Cairo University
Conditions:
Tourniquet Hypertension
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
Brief Summary
Knee pain is very common, and more people are having minor knee surgeries done through a small camera (arthroscopy), often as outpatients. During these surgeries, a device called a tourniquet is used ...
Detailed Description
Knee pain is very common and ambulatory knee arthroscopic surgery has increased significantly. Clinical studies comparing spinal anaesthesia to general anaesthesia (GA), have found that GA resulted in...
Eligibility Criteria
Inclusion
- Patients (males and females) of ASA class I or II, age from 18-60 years old, undergoing ambulatory knee arthroscopy under general anaesthesia using tourniquet.
Exclusion
- Patients with uncontrolled systemic diseases (e.g., diabetes mellitus, hypertension, and chronic obstructive lung disease),
- Patients with significant organ dysfunctions (e.g., cardiac, respiratory, renal, or liver disorders).
- Patients with morbid obesity (BMI \>35).
- Patients with a history of allergy to the drugs used in this study.
- Patients who have history of chronic use of opioids.
- Cases with tourniquet times of less than 60 minutes or longer than 150 minutes were excluded.
Key Trial Info
Start Date :
March 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2025
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT06936410
Start Date
March 1 2025
End Date
August 1 2025
Last Update
April 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Alainy Hospital- Cairo University
Cairo, Egypt